204 related articles for article (PubMed ID: 26826278)
1. Development of a novel multiplex electrochemiluminescent-based immunoassay for quantification of human serum IgG against 10 Staphylococcus aureus toxins.
Adhikari RP; Haudenschild C; Sterba PM; Sahandi S; Enterlein S; Holtsberg FW; Aman MJ
J Immunol Methods; 2016 Mar; 430():33-42. PubMed ID: 26826278
[TBL] [Abstract][Full Text] [Related]
2. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
4. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
5. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
6. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
7. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood.
Takahashi N; Hattori M; Miwa K; Nishida H
Am J Perinatol; 2006 Oct; 23(7):413-9. PubMed ID: 17004199
[TBL] [Abstract][Full Text] [Related]
9. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
[TBL] [Abstract][Full Text] [Related]
10. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
11. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
[No Abstract] [Full Text] [Related]
12. Development of a novel multiplex electrochemiluminescent-based immunoassay to aid enterotoxigenic Escherichia coli vaccine development and evaluations.
Chakraborty S; Brubaker J; Harro C; Weirzba T; Sack D
J Immunol Methods; 2019 Jul; 470():6-14. PubMed ID: 31004579
[TBL] [Abstract][Full Text] [Related]
13. [A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood].
Okada T; Furukawa S; Miwa K; Sakai R; Sugiyama J
Kansenshogaku Zasshi; 1999 Sep; 73(9):893-900. PubMed ID: 10535264
[TBL] [Abstract][Full Text] [Related]
14. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.
Brown EL; Bowden MG; Bryson RS; Hulten KG; Bordt AS; Forbes A; Kaplan SL
Clin Vaccine Immunol; 2009 Jan; 16(1):139-41. PubMed ID: 19005019
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection.
Croze M; Dauwalder O; Dumitrescu O; Badiou C; Gillet Y; Genestier AL; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2009 Feb; 15(2):144-8. PubMed ID: 19154491
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
Bavari S; Ulrich RG; LeClaire RD
J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
[TBL] [Abstract][Full Text] [Related]
17. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.
Fritz SA; Tiemann KM; Hogan PG; Epplin EK; Rodriguez M; Al-Zubeidi DN; Bubeck Wardenburg J; Hunstad DA
Clin Infect Dis; 2013 Jun; 56(11):1554-61. PubMed ID: 23446627
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of toxins during Staphylococcus aureus infection.
Verkaik NJ; Dauwalder O; Antri K; Boubekri I; de Vogel CP; Badiou C; Bes M; Vandenesch F; Tazir M; Hooijkaas H; Verbrugh HA; van Belkum A; Etienne J; Lina G; Ramdani-Bouguessa N; van Wamel WJ
Clin Infect Dis; 2010 Jan; 50(1):61-8. PubMed ID: 19947854
[TBL] [Abstract][Full Text] [Related]
19. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
[TBL] [Abstract][Full Text] [Related]
20. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
